 Krista Eschbach
Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistant Epilepsy | 19 | 2025 | 105 | 4.280 |
Why?
| | Status Epilepticus | 13 | 2025 | 54 | 3.840 |
Why?
| | Epilepsies, Myoclonic | 4 | 2020 | 57 | 1.780 |
Why?
| | Epilepsy | 12 | 2026 | 359 | 1.600 |
Why?
| | Seizures, Febrile | 5 | 2025 | 22 | 1.520 |
Why?
| | Anticonvulsants | 6 | 2025 | 222 | 1.100 |
Why?
| | Gastrointestinal Diseases | 1 | 2025 | 207 | 0.790 |
Why?
| | Electroencephalography | 8 | 2024 | 522 | 0.700 |
Why?
| | Seizures | 11 | 2025 | 441 | 0.670 |
Why?
| | Neurology | 1 | 2021 | 112 | 0.630 |
Why?
| | Dioxolanes | 1 | 2019 | 6 | 0.610 |
Why?
| | Patient Admission | 1 | 2021 | 203 | 0.600 |
Why?
| | Nervous System Diseases | 1 | 2021 | 278 | 0.560 |
Why?
| | Developmental Disabilities | 2 | 2020 | 288 | 0.560 |
Why?
| | Brain Waves | 1 | 2018 | 45 | 0.560 |
Why?
| | Quality of Life | 5 | 2025 | 3024 | 0.540 |
Why?
| | Patient Safety | 1 | 2021 | 335 | 0.530 |
Why?
| | Thyrotropin | 1 | 2017 | 116 | 0.520 |
Why?
| | Child | 28 | 2026 | 22390 | 0.510 |
Why?
| | Caregivers | 1 | 2024 | 940 | 0.500 |
Why?
| | Epileptic Syndromes | 4 | 2024 | 92 | 0.490 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 314 | 0.450 |
Why?
| | Diet, Ketogenic | 3 | 2024 | 36 | 0.420 |
Why?
| | Testosterone | 1 | 2017 | 404 | 0.410 |
Why?
| | Child, Preschool | 18 | 2026 | 11511 | 0.380 |
Why?
| | Telemedicine | 1 | 2021 | 893 | 0.370 |
Why?
| | Encephalitis | 2 | 2025 | 137 | 0.350 |
Why?
| | Adolescent | 17 | 2026 | 22116 | 0.340 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 2210 | 0.300 |
Why?
| | Infant | 12 | 2026 | 9820 | 0.290 |
Why?
| | Registries | 3 | 2025 | 2205 | 0.270 |
Why?
| | Male | 20 | 2026 | 70140 | 0.250 |
Why?
| | Humans | 35 | 2026 | 141284 | 0.250 |
Why?
| | Neurosurgical Procedures | 2 | 2025 | 199 | 0.250 |
Why?
| | Female | 21 | 2026 | 75814 | 0.250 |
Why?
| | Young Adult | 10 | 2025 | 13727 | 0.240 |
Why?
| | Prodromal Symptoms | 1 | 2025 | 19 | 0.220 |
Why?
| | Retrospective Studies | 10 | 2025 | 16447 | 0.210 |
Why?
| | Psychosurgery | 1 | 2023 | 9 | 0.210 |
Why?
| | Databases, Factual | 3 | 2024 | 1449 | 0.210 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2024 | 96 | 0.210 |
Why?
| | Intralaminar Thalamic Nuclei | 1 | 2024 | 20 | 0.210 |
Why?
| | Immunotherapy | 2 | 2025 | 641 | 0.190 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 2021 | 255 | 0.190 |
Why?
| | Fever | 1 | 2024 | 310 | 0.190 |
Why?
| | Genetic Testing | 2 | 2022 | 462 | 0.180 |
Why?
| | Laser Therapy | 1 | 2023 | 128 | 0.180 |
Why?
| | Middle Aged | 10 | 2025 | 34658 | 0.180 |
Why?
| | GABA Modulators | 1 | 2021 | 13 | 0.180 |
Why?
| | Adult | 11 | 2025 | 39319 | 0.170 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 2 | 2019 | 21 | 0.170 |
Why?
| | Interviews as Topic | 1 | 2024 | 839 | 0.170 |
Why?
| | Deep Brain Stimulation | 1 | 2024 | 194 | 0.170 |
Why?
| | Palliative Care | 2 | 2024 | 820 | 0.160 |
Why?
| | Referral and Consultation | 1 | 2026 | 802 | 0.160 |
Why?
| | Cerebral Palsy | 1 | 2022 | 128 | 0.160 |
Why?
| | Spasms, Infantile | 1 | 2021 | 133 | 0.160 |
Why?
| | Healthcare Disparities | 1 | 2026 | 674 | 0.150 |
Why?
| | Drug Approval | 1 | 2019 | 87 | 0.140 |
Why?
| | Treatment Outcome | 8 | 2025 | 11216 | 0.140 |
Why?
| | Lennox Gastaut Syndrome | 1 | 2018 | 19 | 0.140 |
Why?
| | Communication | 1 | 2024 | 941 | 0.140 |
Why?
| | Cytokines | 1 | 2025 | 2079 | 0.130 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 5653 | 0.130 |
Why?
| | Cohort Studies | 4 | 2020 | 5809 | 0.130 |
Why?
| | Body Height | 1 | 2017 | 200 | 0.120 |
Why?
| | Follow-Up Studies | 1 | 2025 | 5222 | 0.120 |
Why?
| | Inflammation | 1 | 2025 | 2840 | 0.100 |
Why?
| | Body Weight | 1 | 2017 | 992 | 0.100 |
Why?
| | Mutation | 3 | 2021 | 4006 | 0.100 |
Why?
| | Quality Improvement | 1 | 2021 | 1241 | 0.090 |
Why?
| | Aged | 6 | 2025 | 24836 | 0.080 |
Why?
| | Risk Factors | 1 | 2021 | 10490 | 0.060 |
Why?
| | Infant, Newborn | 3 | 2024 | 6270 | 0.060 |
Why?
| | Prospective Studies | 3 | 2025 | 7805 | 0.060 |
Why?
| | Blood Cell Count | 1 | 2025 | 52 | 0.060 |
Why?
| | Atrophy | 1 | 2025 | 195 | 0.050 |
Why?
| | Florida | 1 | 2024 | 116 | 0.050 |
Why?
| | Corpus Callosum | 1 | 2023 | 69 | 0.050 |
Why?
| | Rituximab | 1 | 2024 | 204 | 0.050 |
Why?
| | Video Recording | 1 | 2024 | 197 | 0.050 |
Why?
| | Probability | 1 | 2023 | 307 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2025 | 3734 | 0.050 |
Why?
| | Social Determinants of Health | 1 | 2026 | 275 | 0.050 |
Why?
| | Subdural Space | 1 | 2021 | 7 | 0.040 |
Why?
| | Preoperative Care | 1 | 2024 | 372 | 0.040 |
Why?
| | Stereotaxic Techniques | 1 | 2021 | 40 | 0.040 |
Why?
| | Neuroimaging | 1 | 2023 | 278 | 0.040 |
Why?
| | Infectious Encephalitis | 1 | 2020 | 2 | 0.040 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 147 | 0.040 |
Why?
| | Electrodes, Implanted | 1 | 2021 | 112 | 0.040 |
Why?
| | Valproic Acid | 1 | 2020 | 45 | 0.040 |
Why?
| | Potassium Channels | 1 | 2021 | 144 | 0.040 |
Why?
| | Immune System Diseases | 1 | 2021 | 38 | 0.040 |
Why?
| | Animals | 2 | 2021 | 37328 | 0.040 |
Why?
| | Internet | 1 | 2025 | 683 | 0.040 |
Why?
| | Family | 1 | 2024 | 677 | 0.040 |
Why?
| | Disease Management | 1 | 2024 | 634 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2025 | 2069 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2021 | 224 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2024 | 579 | 0.040 |
Why?
| | DNA Polymerase gamma | 1 | 2019 | 8 | 0.040 |
Why?
| | Cannabinoids | 1 | 2021 | 178 | 0.040 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 2019 | 34 | 0.040 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2019 | 41 | 0.040 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 48 | 0.040 |
Why?
| | Cannabidiol | 1 | 2021 | 126 | 0.040 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2024 | 908 | 0.030 |
Why?
| | Family Health | 1 | 2019 | 194 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2021 | 429 | 0.030 |
Why?
| | Receptors, GABA-A | 1 | 2019 | 141 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2019 | 213 | 0.030 |
Why?
| | Anxiety | 1 | 2025 | 1078 | 0.030 |
Why?
| | Age Factors | 1 | 2025 | 3295 | 0.030 |
Why?
| | Prognosis | 1 | 2025 | 4080 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 1035 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 605 | 0.030 |
Why?
| | Time Factors | 1 | 2025 | 6951 | 0.030 |
Why?
| | Phenotype | 1 | 2021 | 3172 | 0.020 |
Why?
| | Brain | 1 | 2025 | 2857 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1483 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 5948 | 0.020 |
Why?
| | United States | 1 | 2026 | 15298 | 0.020 |
Why?
|
|
Eschbach's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|